- Home
- APM vs AMIX Comparison
APM vs AMIX Comparison
Compare APM & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- AMIX
- Stock Information
- Founded
- APM 2010
- AMIX 2014
- Country
- APM United Kingdom
- AMIX United States
- Employees
- APM N/A
- AMIX N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- APM Health Care
- AMIX
- Exchange
- APM Nasdaq
- AMIX NYSE
- Market Cap
- APM 6.1M
- AMIX 4.9M
- IPO Year
- APM 2018
- AMIX N/A
- Fundamental
- Price
- APM $0.93
- AMIX $1.72
- Analyst Decision
- APM
- AMIX Strong Buy
- Analyst Count
- APM 0
- AMIX 1
- Target Price
- APM N/A
- AMIX $5.00
- AVG Volume (30 Days)
- APM 137.3K
- AMIX 159.3K
- Earning Date
- APM 05-20-2025
- AMIX 05-30-2025
- Dividend Yield
- APM N/A
- AMIX N/A
- EPS Growth
- APM N/A
- AMIX N/A
- EPS
- APM N/A
- AMIX N/A
- Revenue
- APM N/A
- AMIX N/A
- Revenue This Year
- APM N/A
- AMIX N/A
- Revenue Next Year
- APM N/A
- AMIX N/A
- P/E Ratio
- APM N/A
- AMIX N/A
- Revenue Growth
- APM N/A
- AMIX N/A
- 52 Week Low
- APM $0.46
- AMIX $1.52
- 52 Week High
- APM $7.49
- AMIX $75.80
- Technical
- Relative Strength Index (RSI)
- APM 52.79
- AMIX 43.94
- Support Level
- APM $0.80
- AMIX $2.10
- Resistance Level
- APM $0.96
- AMIX $2.82
- Average True Range (ATR)
- APM 0.07
- AMIX 0.20
- MACD
- APM -0.00
- AMIX -0.03
- Stochastic Oscillator
- APM 68.36
- AMIX 10.53
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.